PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics

April 10, 2018 at 8:15 AM EDT PDF Version First Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 10, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with Helix, a personal genomics company,... Read more

Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

SAN DIEGO & STAMFORD, Conn.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) today announced a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling, resulting in a distributable, next-generation sequencing (NGS) based companion diagnostic (CDx) with a pan-cancer indication. The co-development partnership will seek approval for a version... Read more

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018

Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018 SANTA CLARA, Calif., April 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its line-up of innovative solutions for laboratory efficiency at Analytica, being held April 10 – 13, in Munich, Germany. This year at the 26th international trade fair for... Read more

ATCC Awarded 10-year US Department of Defense Joint Program Executive Office Chemical and Biological Defense JE-RDAP Contract

Providing the DoD with premier biological materials and services MANASSAS, Va., April 6, 2018 /PRNewswire-USNewswire/ — ATCC, a global leader in biological materials development, management and standards, today announced it has been awarded a 10-year contract through the U.S. Department of Defense’s (DoD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP), an omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle to... Read more

Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing

New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results (ANN ARBOR, Mich. – April 6, 2018) Swift Biosciences today announced the launch of its Accel-NGS® Unique Dual Indexing Kits, which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in samples such... Read more

New England Biolabs® Launches “Lessons from Lab & Life™” Podcast

Monthly episodes feature intimate conversations between scientific colleagues on science, careers and backstories that changed their lives; now available on iTunes. IPSWICH, Mass., April 5, 2018 /PRNewswire/ — Scientists face many extraordinary crossroads in their careers, few of which have easy answers. To give people a window into those pivotal moments, New England Biolabs (NEB®) today announced... Read more

10x Genomics Becomes a Partner in the CanSeq150 Initiative

–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—April 5, 2018—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes... Read more

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

SnapGene and VectorBuilder Partner to Streamline DNA Cloning

April 4, 2018 Biologists can now use SnapGene software to order plasmids directly through VectorBuilder.Chicago, IL – April 4 GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from VectorBuilder through GSL Biotech’s “SnapGene” software. SnapGene was created to meet the everyday needs of... Read more

Dr. David Sinclair Joins Zymo Research Corp.’s Scientific Advisory Board

One of the most important thought leaders in the aging field Dr. David A. Sinclair, an anti-aging specialist, joins Zymo Research’s Scientific Advisory Board. IRVINE, Calif., April 3, 2018 /PRNewswire/ — The Zymo Research Corp. Board of Directors has announced the appointment of David A. Sinclair, Ph.D., O.A., Professor, Principal Investigator and Co-Director of the Paul F. Glenn Labs... Read more